Kriya Therapeutics
Kriya Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded in 2019 that designs, develops and manufactures one-time AAV gene therapies for chronic diseases that affect large patient populations, rather than for ultra-rare indications alone. It is headquartered at 1219 Shiloh Glenn Drive in Durham, North Carolina, inside Research Triangle Park, with additional operations in Palo Alto, California, and has raised more than $900 million across Series A ($80M, 2020), Series B ($100M, 2021), Series C (over $430M including a $150M extension, 2022-2023) and Series D ($320M, September 2025). Its pipeline spans three therapeutic areas: ophthalmology (geographic atrophy, thyroid eye disease including KRIYA-586), metabolic disease (Type 1 diabetes, MASH/NASH, an investigational AAV-FGF21 program) and neurology (trigeminal neuralgia, added through the 2022 acquisition of Redpin Therapeutics). The company operates a vertically integrated engine that pairs computational product design with in-house GMP manufacturing — the same unit operations from 1L research scale through 50L, 500L and 3,000L bioreactor scale, with Akta chromatography purification, vial filling and in-house analytical characterization of critical quality attributes. It was selected for the FDA PreCheck Pilot Program in June 2026. Kriya Therapeutics runs no developer program and publishes no product API, no developer portal and no API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind kriyatherapeutics.com, catalogued here.
Kriya Therapeutics publishes 10 APIs on the APIs.io network, including Discovery API, Forms API, Media API, and 7 more. Tagged areas include Company, biotechnology, pharmaceuticals, gene-therapy, and aav.
Kriya Therapeutics’ developer surface includes product news, support, authentication, and 27 more developer resources.
Kin Score
APIs 10
Individual APIs this provider publishes, each with its own machine-readable definition.
Kriya Therapeutics Discovery API
Route, type, taxonomy and status discovery documents.
Kriya Therapeutics Forms API
The `gutena_forms` custom post type used for the site contact form.
Kriya Therapeutics Media API
Media library (304 attachments at harvest time).
Kriya Therapeutics News API
The `news` custom post type — the company press-release archive (28 items at harvest, back to May 2020).
Kriya Therapeutics Oembed API
oEmbed 1.0 provider endpoint for kriyatherapeutics.com URLs.
Kriya Therapeutics Pages API
Corporate and pipeline pages (18 published at harvest time).
Kriya Therapeutics Posts API
Core blog/post collection (33 items at harvest).
Kriya Therapeutics Search API
Cross-content search across published objects.
Kriya Therapeutics Taxonomy API
Categories, tags, news categories and team keywords.
Kriya Therapeutics Team API
The `team` custom post type. Registered and reachable, but empty (X-WP-Total 0) — the Team page is authored as page markup.
Scroll for all 10
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 4
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 8
Properties that don't map to a standard resource type
Scroll for all 8